Sell. DoubleZero is showing broad and persistent downside momentum: 2Z is down 8.65% over 24 hours and 40.31% over seven days, with further losses of 29.23% over 14 days and 26.26% over 30 days. The seven-day decline is the steepest of the reported periods, underscoring the severity of the recent weakness.

The current price of $0.03833 sits below every supplied hourly moving average, from the 8-period SMA at $0.0393 to the 144-period SMA at $0.0464. The longer-period averages are also higher than the shorter-period ones, consistent with the negative alignment in these data; price being below all of them is a clear bearish signal, though the averages alone do not establish how long the decline will continue.

Price is close to the 24-hour low of $0.03798 and well below the high of $0.04232, reinforcing the weak daily picture. The supplied daily range is $0.00434, but without comparable historical ranges it does not establish whether volatility is unusually high.

The RSI readings provide the main counterpoint to the bearish trend: the 1-hour RSI is 22 and the 7-day RSI is 31, indicating oversold conditions on the shorter timeframe and weakness on the weekly one. The low hourly reading leaves room for a short-term rebound, but it is not confirmation of a reversal and does not outweigh the falling prices and below-average position.

Reported 24-hour volume is 14,309,120, with volume equal to 7.26% of market capitalization. These figures provide activity context, but without a historical comparison or buy-versus-sell breakdown they do not independently confirm either accumulation or selling pressure.

The price is also far below the reported all-time high of $0.893679, although that comparison describes the scale of the decline rather than a near-term trading signal. Overall, the persistent negative returns and price below all listed moving averages outweigh the oversold RSI readings, which signal possible rebound risk but not a demonstrated change in direction.

The rating is Sell because the strongest supplied evidence points to continued downside momentum across daily, weekly, and monthly performance measures. The primary opposing evidence is the oversold RSI, but no price recovery or other reversal confirmation is provided.